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Rett syndrome (RTT), a neurodevelopmental disorder affecting mostly females, is caused by mutations in the X-
linked gene encoding methyl-CpG–binding protein 2 (MeCP2). Although the majority of girls with classic RTT
have a random pattern of X-chromosome inactivation (XCI), nonbalanced patterns have been observed in patients
carrying mutantMECP2 and, in some cases, account for variability of phenotypic manifestations. We have generated
an RTT mouse model that recapitulates all major aspects of the human disease, but we found that females exhibit
a high degree of phenotypic variability beyond what is observed in human patients with similar mutations. To
evaluate whether XCI influences the phenotypic outcome of Mecp2 mutation in the mouse, we studied the pattern
of XCI at the single-cell level in brains of heterozygous females. We found that XCI patterns were unbalanced,
favoring expression of the wild-type allele, in most mutant females. It is notable that none of the animals had
nonrandom XCI favoring the mutant allele. To explore why the XCI patterns favored expression of the wild-type
allele, we studied primary neuronal cultures from Mecp2-mutant mice and found selective survival of neurons in
which the wild-type X chromosome was active. Quantitative analysis indicated that fewer phenotypes are observed
when a large percentage of neurons have the mutant X chromosome inactivated. The study of neuronal XCI patterns
in a large number of female mice carrying a mutant Mecp2 allele highlights the importance of MeCP2 for neuronal
viability. These findings also raise the possibility that there are human females who carry mutant MECP2 alleles
but are not recognized because their phenotypes are subdued owing to favorable XCI patterns.
Introduction
Rett syndrome (RTT [MIM 312750]) is a neurodevelop-
mental disorder that affects predominantly females (Rett
1966; Hagberg et al. 1983; Rett Syndrome Diagnostic
Criteria Work Group 1988). RTT is caused by mutations
in MECP2, a gene, located on Xq28, that encodes for
methyl-CpG–binding protein 2 (MeCP2) (Amir et al.
1999). Girls with classic RTT appear normal from birth
until ∼6–18 mo of age, but then they fail to acquire new
milestones and enter a period of regression during which
motor and language skills are lost. These girls also have
poor coordination, tremor, impaired social interaction,
and stereotypic hand movements. In addition to these
classic phenotypes, a vast range of phenotypes has been
observed in patients with MECP2 mutations, including
milder and more-severe forms of the disease. Patients with
more-severe phenotypes develop the disease shortly after
birth, without the period of normal development, and
often have congenital hypotonia and infantile spasms.
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Patients with a milder variant may retain some speech
and motor functions and do not have seizures (Hagberg
1995). In addition, MECP2 mutations have been asso-
ciated with non-RTT phenotypes, including neonatal-
onset encephalopathy; Angelman syndrome phenotype
(Watson et al. 2001); mild, nonspecific mental retarda-
tion (Orrico et al. 2000; Yntema et al. 2002); and autism
(Lam et al. 2000; Carney et al. 2003).
Several factors could explain this phenotypic variabil-
ity, including mutation type and location, cis- and trans-
acting modifiers, and the degree of cellular mosaicism for
the mutant allele. The latter could be in the form of so-
matic mosaicism in males or nonrandom X-chromosome
inactivation (XCI) in females, given that MECP2 is sub-
ject to XCI (Adler et al. 1995). Although the majority of
patients with classic RTT have balanced XCI patterns in
brain tissue (Shahbazian et al. 2002b), nonrandom pat-
terns of XCI were observed in several cases (Renieri et
al. 2003; Weaving et al. 2003). In particular, nonrandom
XCI patterns favoring expression of the wild-type allele
can enable females who carry classic RTT–causing mu-
tations to be asymptomatic (Sirianni et al. 1998). If the
mutation is severe (e.g., if the protein is absent or largely
truncated), skewed XCI patterns can also enable females
to have a milder phenotype than the mutation would
predict (Wan et al. 1999; Bienvenu et al. 2000; Ishii et
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Figure 1 Penetrance of phenotypes caused by the Mecp2308 allele. Each of the four panels shows an image of a mutant female mouse and
of a wild-type female litter mate (inset). The percentage of animals of each sex manifesting a particular phenotype is shown below each panel.
A, Representative image of a female with DF. The inset shows a wild-type litter mate with shiny and groomed fur. B, A picture taken at a shutter
speed of 1 s reveals the tremor as a shadow effect over the mouse’s silhouette (arrows). The sharp inset picture of a wild-type mouse was taken
at the same shutter speed. C, PLs that sometimes extend to the ears. Note also the disarranged appearance of the fur. Inset shows a normal
eye in a wild-type litter mate. D, SFMs, inferred by looking at this picture taken with a shutter speed of 1 s. The arrow points to the forepaws
of the mutant female, which have a shadow because of the rapid movements (see video by Shahbazian et al. [2002a] at the Neuron Web site).
al. 2001; Zappella et al. 2001; Huppke et al. 2002).
Recently, a girl with a 47,XXX karyotype and an RTT-
causing MECP2 mutation has been reported to have a
relatively mild, atypical form of RTT owing to unbal-
anced XCI patterns favoring one or the other maternal
alleles, thus illustrating an interesting example of poten-
tial effects of XCI skewing (Hammer et al. 2003).
Studies of XCI in humans rely mainly on methylation
patterns of X-linked polymorphic markers to distinguish
the active from the inactive chromosome in blood or epi-
thelial cells. Discordances between these two determi-
nations have been repeatedly reported, suggesting that
XCI in the brain cannot always be predicted on the
basis of the study of peripheral tissues (Temudo and
Maciel 2002). This poses a limitation for the study of
XCI in RTT, as the associated phenotype is predomi-
nantly, if not exclusively, of neurologic origin. In ad-
dition, the type of mutation and the quality of care could
also affect the clinical manifestations of the patients
(Sharp et al. 2000).
So far, genotype-phenotype studies in mice have been
limited to only two mutations, comprising null and hy-
pomorphic alleles of Mecp2 (Chen et al. 2001; Guy et
al. 2001; Shahbazian et al. 2002a). The former resembles
more severe cases of RTT than the latter, as evidenced
by the phenotypes of the mutant males. It is interesting
that, although the female mice develop a progressive neu-
rological phenotype in both cases, the degree of varia-
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Figure 2 Determination of XCI patterns in the cerebellum of Mecp2308/X females by confocal laser scanning microscopy. Costaining with
anti-calbindin antibody (red) and an antibody against the C-terminus of MeCP2 (green) (see lower diagram for antigen localization) allows us to
label all PCs (calbindin) and identify neurons that express the wild-type Mecp2 allele (cells positive for calbindin and Mecp2 have yellow nuclei).
Note that the majority of PCs are immunoreactive for the MeCP2 antibody. Arrows mark the few cells expressing mutant Mecp2 (nonim-
munoreactive for a-MeCP2). Each panel is a representative example of immunofluorescence, visualized at increasingly higher magnifications.
Scale bar p 20 mm.
bility and patterns of XCI have not been documented
from either mutant. To this end, we set out to investigate
the patterns of XCI and their effect on the phenotypic
outcome in female mice carrying the hypomorphic
Mecp2308 mutation (Mecp2308/X) that results in the pro-
tein truncated at amino acid 308, similar to mutations
found in patients with RTT (Shahbazian et al. 2002a).
The study of XCI patterns in female mice carrying a
mutant Mecp2 allele has several advantages. It allows
the study of an unselected large population of females
that have an identical genetic background and the same
Mecp2 mutation. In mice, one can also control for en-
vironmental factors—such as diet, rearing, and nurtur-
ing—that could affect the phenotypic manifestations.
We found that the XCI patterns in most Mecp2308/X–
mutant females were unbalanced, favoring expression
of the wild-type allele. It is interesting that none of the
animals had nonrandom XCI favoring expression of the
mutant allele. Quantitative genotype-phenotype studies
indicated that the unbalanced XCI patterns mitigate sev-
eral phenotypes in the Mecp2308/X mice.
Material and Methods
Mouse Breeding and Phenotyping
For all the experiments described in this article, 6- or
12-month–old mice of a pure 129/SvEv genetic back-
ground were used. Physical characteristics of mice, such
as appearance of fur and periocular region, were noted.
Presence of body tremor (Tr) and forepaw stereotypies
were assessed by holding the mice in the palm and sus-
pending them by their tails, respectively.
Immunofluorescence
Mouse brains were fixed by transcardial perfusion fol-
lowed by overnight immersion in PBS-buffered 4% for-
maldehyde. The brains were embedded in O.C.T. (Tissue
Tek) and cryosectioned (50 mm). Sections were blocked
for 1 h in 2% normal goat serum and 0.3% triton X-
100 in PBS. After blocking, the sections were incubated
for 48 h at 4C in blocking solution containing primary
anti-MeCP2 antibody (Upstate) (1:100) in combination
with antibodies to one of the following proteins: calbin-
din (1:1,000), tyrosine hydroxylase (1:1,000), or par-
valbumin (1:2,000). The sections were washed four times
in PBS and were incubated for 48 h in blocking solution
containing secondary antibody. Anti-mouse– or anti-
rabbit–conjugated Alexa Fluor 488 (Molecular Probes)
was used at a dilution of 1:500, and anti-mouse– or
anti-rabbit–conjugated Cy3 (Jackson Immunoresearch)
was used at a dilution of 1:500.
Cells in culture were fixed for 30 min in PBS-buffered
4% formaldehyde, were incubated for 15 min in 0.1%
triton X-100 in PBS, and were blocked for 30 min in
1% bovine serum albumin, 2% normal goat serum, and
0.05% triton X-100 in PBS. After blocking, the sections
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Figure 3 Distribution of XCI patterns inMecp2308/X female mice.
Values on the X-axis represent the percentage of cells that have the
wild-type X chromosome active, as assayed by coimmunofluorescence.
Among a total of 45 female mice, none had !54% of cells with the wild-
type chromosome as the active one.
were incubated for 2 h at 4C in blocking solution con-
taining primary anti-MeCP2 antibody (Upstate) (1:150)
in combination with antityrosine-tubulin (TUB-1A2) (1:
1,000).
Sections were washed as described above and were
mounted on microscope slides, with Prolong (Molecular
Probes) as mounting media. Cell counting was done
manually by going through image stacks of optical sec-
tions collected using a Zeiss 510 confocal microscope.
Only cells visualized in their totality were counted. Toto-
3–iodide (molecular probes) staining of nuclear DNA per-
formed in a subset of sections was consistent with the
results obtained using confocal analysis.
Culture of Primary Neurons
Hippocampal neurons were prepared from embryonic
day 18 (E18) 129/SvEv embryos, derived from an
Mecp2/Y–Mecp2308/X mating. Embryos were sexed by mi-
croscopic examination of internal reproductive organs,
and neurons from male hippocampi were paired in every
possible combination and were plated in duplicate cham-
bers. Neurons from female embryos were plated in du-
plicate chambers without pooling. Dissociated cells were
plated on poly-D-lysine–coated Lab-TekII glass cham-
bers in Neurobasal medium supplemented with 2% B27,
0.5 mM L-glutamine, and 25 mM glutamate. After 3 d,
the medium was changed to Neurobasal/2% B27 with-
out glutamate. Genotyping and sex confirmation of the
embryos was performed by PCR, as described elsewhere
(Kunieda et al. 1992; Shahbazian et al. 2002a). Neu-
ronal cultures from Mecp2308/X female mice were fixed
and stained for immunofluorescence after 4 d and 7 d
in culture, whereas cocultures from male mice of different
genotypes were fixed and stained for immunofluorescence
after 7 d in culture.
Statistical Analysis
Logistic regression was used to determine the associa-
tion between the absolute level of XCI and the presence
of each phenotype. A x2 test was used to determine the
association among three groups on the basis of XCI
patterns (group 1 54%–70%, group 2 71%–77%, and
group 3 178%) and the presence of each phenotype. The
Kruskal-Wallis test was used to compare the three XCI-
pattern groups, with respect to percentage of phenotypes
manifested.
Results
High Degree of Phenotypic Variability in Mecp2308/X
Female Mice
Initial phenotypic characterization ofMecp2308/X female
mice indicated that there is variability in the phenotypic
manifestations (Shahbazian et al. 2002a). To ascertain the
extent and degree of phenotypic variability in a large num-
ber of animals, we focused on phenotypes that seemed to
be fully penetrant in males and that are easily scored.
Four phenotypes fulfilled the set criteria: (1) Tr, which
typically appears at age 5 wk in males and is the first
observable abnormality; (2) stereotypic forepaw move-
ments (SFM), also evident early and a cardinal feature of
classic RTT; (3) disheveled fur (DF), which could be a
consequence of poor grooming related to the observed
hypoactivity; and (4) periocular lesions (PL). Mutant mice
develop periocular inflammation and bleeding (fig. 1C),
usually accompanied by bacterial infections. The lesions
appear as early as age 6 wk in males. The cause of this
phenotype remains elusive, but one hypothesis posits that
these lesions could result from excessive stereotypic face
scratching, a behavior that has been observed in patients
with RTT (Hammer et al. 2002).
The presence or absence of these four phenotypes was
noted in 108 males and in 84 females at age 6 mo and
12 mo, respectively. We did not score for the degree of
severity, to avoid any ambiguity or subjectivity in the
scoring. Last, we chose 12 mo as testing age for females,
because the disease may occur later and progress more
slowly in females than in males. All four phenotypes were
∼100% penetrant in males, whereas the penetrance var-
ied from 44% to 68% in females (fig. 1).
XCI Is Predominantly Nonrandom in Favor
of Expression of the Wild-Type Mecp2 Allele
Variable patterns of XCI have been suggested as modi-
fiers of clinical severity in human patients (Zoghbi et al.
1990; Amir et al. 2000; Bienvenu et al. 2000; Hoffbuhr
et al. 2002). To evaluate whether XCI patterns influence
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Figure 4 XCI patterns in midbrain and cerebral cortex of Mecp2308/X female mice. A and B, Double immunofluorescence for the detection
of wild-type MeCP2 (green) and TH (red) was used to determine the XCI pattern in catecholaminergic neurons in the midbrain. Arrows denote
cells that have the X chromosome bearing the mutant Mecp2 as the active one. C, Visualization of coimmunolabeling of Mecp2 (green) and
parvalbumin (red) in the cerebral cortex by confocal microscopy. D, Same as in panel C, but a single focal section is shown, to demonstrate
the definitive identification of cells expressing the wild-type (arrowhead) versus the mutant (arrow) Mecp2 allele. Scale bar p 20 mm.
the phenotypic outcome of the Mecp2308 mutation, we
studied the pattern of XCI in the brains of Mecp2308/X
females. To analyze the XCI patterns at the cellular level,
we performed double immunofluorescence labeling, using
an antibody directed against the C-terminus of MeCP2,
which is deleted in the Mecp2308 allele and an antibody
against calbindin; thus, the MeCP2 antibody will label
only cells carrying the wild-type X chromosome as the
active one, whereas the antibody against calbindin will
label every Purkinje cell (PC) (fig. 2). The MeCP2 an-
tibody labels all PCs in the cerebella of wild-type female
mice (data not shown), whereas there is no immuno-
reactivity on cerebella of male mice carrying truncated
MeCP2 (Shahbazian et al. 2002a).
A quantitative analysis was done for 45 brains from
12-mo-old Mecp2308/X female mice by counting200 PCs
per cerebellum. We observed variability in the patterns
of XCI in PCs, with a range of 54%–82% (percentage
of cells with the chromosome carrying the wild-type al-
lele active). It is important to note that we observed that
160% of the females tested exhibited unbalanced XCI
patterns (fig. 3). It is notable that the unbalanced pattern
was always in favor of cells carrying the wild-type X
chromosome as the active chromosome, as evidenced by
the absence of females with !54% of cells with the wild-
type X chromosome active. Immunostaining with an an-
tibody directed against the N-terminus of MeCP2 (Shah-
bazian et al. 2002a), present in both the wild-type and
the truncated MeCP2, labeled virtually every PC in the
cerebella of Mecp2308/X female mice. This confirms that
PCs that failed to label with the C-terminal anti-MeCP2
antibody were, in fact, expressing the truncated protein
and carry an inactivated wild-type X chromosome.
Variability in XCI Patterns in Different Brain Regions
The observation that the majority of females exhibited
nonrandom XCI patterns in PCs prompted us to inves-
tigate whether the same skewing is observed in different
cell populations throughout the brain. For this purpose,
we performed double immunofluorescence with the same
anti-MeCP2 (C-terminus) combined with anti-calbindin,
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Table 1
XCI Patterns in Neurons From Different Brain Regions of Mecp2308/X Female Mice
MOUSE
PERCENTAGE (NO. OF NEURONS ANALYZED)





Cortical Neurons Tr SFM DF PL
1 62.0 (200) 61.2 (56) 64.7 (153)   
2 75.0 (200) 70.9 (72) 68.8 (125)   
3 75.0 (200) 71.9 (64) 76.9 (130)   
4 78.0 (200) 85.9 (71) 55.9 (177)   
5 80.0 (200) 77.5 (49) 76.0 (121) 
6 80.0 (200) 51.2 (82) 78.0 (182)  
7 81.0 (200) 80.9 (63) 82.9 (94) 
anti-TH (tyrosine hydroxylase), or antiparvalbumin anti-
bodies on serial sections from seven Mecp2308/X female
mouse brains. Because of the heterogeneity in MeCP2-
expression levels (LaSalle et al. 2001), we focused our
analysis on a specific subset of neurons: catecholaminergic
neurons in the paraventricular hypothalamic nucleus (la-
beled by anti-TH) and on parvalbumin-positive cells in
the cerebral cortex (layers II–VIa) (fig. 4). Two (28.6%)
of seven mice analyzed showed variability across the dif-
ferent regions studied (table 1 [see mice number 4 and
number 6]), whereas the remaining five had similar pat-
terns of XCI in all the regions tested.
Selective Survival of Cells Carrying the Wild-Type
Mecp2 Allele Might Explain Favorable XCI Patterns
Nonrandom XCI may result from both selective and
stochastic processes. In the mouse, the choice of which X
chromosome to inactivate is under the control of the X-
inactivation center and is made during embryonic devel-
opment, sometime between implantation and completion
of gastrulation (Plath et al. 2002). The absence of animals
with XCI patterns favoring expression of the mutant allele
suggests that stochastic events are not responsible for the
observed skewing. However, we cannot rule out defini-
tively the possibility that a dysfunctional MeCP2 has a
primary effect on the X-inactivation process.
To determine the mechanism responsible for the un-
balanced XCI patterns, we resorted to cell culture ex-
periments. We cultured primary neurons derived from
the hippocampus of E18 Mecp2308/X mice, a time when
the virtually irreversible process of XCI has already taken
place. Using the same strategy of coimmunolabeling of
wild-type MeCP2 and a neuronal marker (tyrosine a-
tubulin), we observed that the percentage of cells ex-
pressing the wild-type allele changed from 61% (74 wild
type of 122 total) to 77% (155 wild type of 201 total)
after 3 d in culture (days 4–7) (fig. 5A). Furthermore,
mixing of cultures of cells derived from wild-type
Mecp2/Y and mutant Mecp2308/Y male mice and plating
them at a ratio of ∼1:1 gave rise to a predominantly
wild-type population of neurons after 7 d in culture
( ; ) (fig. 5B). These data suggest67.5% 3.5% Np 2
that there is a selective advantage for cells expressing
the wild-type Mecp2 allele and/or pressure against cells
expressing the mutant allele, highlighting the importance
of MeCP2 in neuronal survival.
Phenotypic Manifestations in Mecp2308/X Female Mice
Mitigated by Unbalanced XCI
The high prevalence of skewing in Mecp2308/X female
mice suggested that the pattern of XCI could be respon-
sible for the variability in their phenotypes. To address
this directly, we looked at how XCI patterns in PCs (by
use of data from 45 brains) correlate with the four phe-
notypes systematically evaluated for the same set of mice.
Logistic regression analysis indicated that the more the
XCI patterns favored expression of the wild-type allele
the less were the odds of exhibiting any of the pheno-
types. The highest level of correlation was observed for
Trs and SFMs, but a correlation was evident for every
phenotype, suggesting that each phenotype is affected by
XCI patterns (fig. 6A).
Another way to study the XCI-phenotype relationship
is to group the mice according to their pattern of XCI,
expressed as the percentage of cells having the wild-type
allele active (54%–70%, 71%–77%, and 178%) and to
plot every group against the cumulative number of phe-
notypes manifested by the mice that belong to that par-
ticular group. We found that significantly fewer pheno-
types are observed when a large percentage of neurons
has the mutant X chromosome silenced, confirming that
the ratio of cells expressing a wild-type versus mutant
MeCP2 is critical for the phenotypic manifestation in
females (fig. 6B).
Discussion
The study of female mice harboring a late-truncating mu-
tation in Mecp2 (Mecp2308) revealed that they exhibit
large variability in phenotypic manifestations. Four phe-
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Figure 5 Selective growth advantage of neurons expressing the wild-type allele when grown in culture. The proportion of neuronsexpressing
either wild-type or truncated Mecp2 allele was determined by indirect immunofluorescence in hippocampal neurons from an E18 female
Mecp2308/X embryo cultured for 4 or 7 d (A) and in neurons from mixed cultures derived from Mecp2308/Y and Mecp2/Y embryos (1:1 ratio)
cultured for 7 d (B). White bars p neurons expressing wild-type MeCP2. Gray bars p neurons expressing truncated MeCP2.
notypes with full penetrance in males (Tr, repetitive fore-
paw movements, periocular injuries, and DF) exhibited
high variability when scored for presence or absence in
the Mecp2308/X female mice. This finding is surprising,
since the range of phenotypes presented by human pa-
tients carrying similar MECP2 mutations is less variable.
Although a small number of patients carrying compa-
rable mutations (such as R294X and Q297X [Ishii et al.
2001]) have been reported to have nonclassic phenotypes,
the majority of patients with similar mutations have clas-
sic RTT (RettBASE: IRSA MECP2 Variation Database).
In a way, the observed high degree of variability in the
Mecp2308/X female mice is counterintuitive, as the dif-
ferential presence of genetic and environmental modi-
fiers that could occur in a human population is most
likely not present in our controlled conditions (pure ge-
netic background and controlled husbandry and housing
conditions).
We found that the majority of the mutant females had
unbalanced XCI patterns. This was another surprising
result, since most female patients with classic RTT have
balanced XCI (Shahbazian et al. 2002b; Armstrong et al.
2003). The XCI patterns in Mecp2308/X female mice were
determined by use of a simple, efficient, and sensitive
method that allows for precise quantification of the pro-
portion of cells that have inactivated the mutant or the
wild-type X chromosome. Using this method, we dem-
onstrate here that the phenotypic variability is accom-
panied by variable XCI patterns and that the majority
of the female mice studied showed unbalanced XCI that
favors the expression of the wild-type allele. Nonrandom
XCI could be caused by a bias in the initial choice of
which X chromosome to inactivate (primary cause) or
by the result of a selection against cells having elected to
inactivate a given X chromosome (secondary cause). Ex-
amples of the former include nonrandom XCI due to
chance events or dysfunction of gene(s) that regulate XCI
(Cattanach et al. 1969; Rastan 1982; Newall et al. 2001).
Examples of secondary causes include many X/autosome
translocations in which there is selection against cells that
inactivate the translocated X chromosome (see, e.g., Mc-
Mahon and Monk [1983]) and several X-linked disorders
in which the mutated gene has deleterious effects in a
cell-autonomous manner (Plenge et al. 2002). Biochemi-
cal studies indicate that XCI is complete in all cells
in female mice by the onset of gastrulation (Monk 1992)
and that the inactive state of the X chromosome is stable
and inherited in female somatic cells throughout the life-
time of the mouse.
We did not find a single female mouse with nonran-
dom XCI patterns favoring expression of the mutant
allele, suggesting that there is a selective advantage of
cells expressing the wild-type Mecp2 allele (consistent
with a secondary cause of nonrandom XCI). This hy-
pothesis is supported by the fact that, although the un-
balanced pattern of XCI was not linked to a particular
region of the brain—in the majority of the cases, it was
rather similar across the analyzed regions (cerebellum,
midbrain, and cerebral cortex)—∼30% of the females
exhibited differences in the patterns of XCI in the brain
regions tested.
Additional support for this hypothesis comes from the
finding that, over time, neurons expressing the wild-type
protein show a relative increase in primary cultures of
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Figure 6 Correlation between degree of XCI skewing and phenotype. We divided the population of 45 females into three groups, according
to their XCI patterns, and plotted them against the percentage of mice expressing a particular phenotype for each range of XCI patterns (A).
Logistic regression analysis indicated that a unit increase in XCI was associated with a 16%, a 21%, a 9%, and a 12% decrease in the odds
of Tr ( ), SFM ( ), DF ( ), and PL ( ), respectively. B, The cumulative number of phenotypes presented by the animalsP ! .01 P ! .01 P ! .06 P ! .02
in each group plotted against the XCI groups. A significant difference was detected among XCI pattern groups ( ), and further testingP ! .001
indicated differences between groups 1 (54%–70%) and 2 (71%–77%) ( ), between groups 1 and 3 (178%) ( ), and betweenP ! .05 P ! .001
groups 2 and 3 ( ).P ! .02
hippocampal cells from Mecp2308/X females, when com-
pared with neurons expressing the mutant allele. Fur-
thermore, the ratio of wild-type and mutant cells cultured
together (obtained from Mecp2/Y and Mecp2308/Y males,
respectively) depart form the initial equality at the ex-
pense of the mutant cells. Although we recognize the
limitations of evaluating the effects of mutations in in
vitro culture conditions, we believe that these data to-
gether with the in vivo data (always favoring the wild-
type allele) strongly support the hypothesis that a selec-
tive advantage of cells expressing the wild-type allele over
the cells expressing the mutant allele accounts for un-
balanced XCI patterns in this mouse model. Balmer et
al. (2002) reported that MECP2 mutations cause a
growth disadvantage in cultured clonal T cells, providing
additional support for our hypothesis. Furthermore, our
results also suggest that the selective advantage that re-
sults in preferential survival or proliferation of wild-type
versus mutant cells does not depend on an anatomical
or histological context. Examination of three diverse neu-
ronal populations and finding nonrandom XCI patterns
in all of them suggests that preferential survival of cells
expressing the wild-type allele can occur in all brain
regions, but we cannot exclude the possibility that some
brain regions or peripheral tissues do not pose this se-
lective advantage and, hence, have balanced XCI pat-
terns. Whether the effect on XCI patterns observed for
the Mecp2308 allele is shared by several or all forms of
dysfunctional MeCP2 remains to be determined. To our
knowledge, only one girl who has the 1157del32 mu-
tation has been reported to show unfavorable XCI pat-
terns, with ∼66% of mutated X active and only 34% of
the normal paternal X active (Zappella et al. 2001). In
that case, the unbalanced pattern is probably a result of
chance, since it is hard to envision a nonfunctional
MeCP2 providing a survival advantage.
Nonrandom XCI patterns can affect the phenotypes
of females carrying mutant X-linked genes (Lyon 2002).
The outcome depends on whether the skewing favors the
normal or the mutant allele-harboring X chromosome.
The effect of XCI patterns on the RTT phenotype is
illustrated by a number of reports of females who carry
MECP2 mutations but who are apparently unaffected,
owing to extreme (90%–100%) unbalanced XCI pat-
terns favoring expression of the X chromosome carrying
the wild-type allele (Sirianni et al. 1998; Wan et al. 1999;
Amir et al. 2000; Bienvenu et al. 2000; Villard et al. 2000;
Hoffbuhr et al. 2001). Other females with MECP2 mu-
tations but with slightly lower levels of skewing (85%–
95%) were reported to have atypical RTT, showing some
but not all diagnostic features of RTT (Hoffbuhr et al.
2001; Zappella et al. 2001). However, the majority of
patients with RTT have balanced XCI patterns (Shah-
bazian et al. 2002b; Armstrong et al. 2003). We hy-
pothesized that this is due to ascertainment bias; if non-
random XCI affects the phenotypic outcome of MECP2
mutations, there might be females who carry mutations
in MECP2 who are asymptomatic or misdiagnosed.
Some of them may be recognized only after having an
affected child, whereas some may go unrecognized if they
are subfertile. To test this hypothesis, we studied the as-
sociation of nonrandom XCI with the phenotypic out-
come of the Mecp2308 mutation. Our results indicate that
XCI patterns affect the phenotypic manifestations. A
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clear correlation was observed between the pattern of
XCI in PC of the cerebellum and the cumulative phe-
notype, so that those females with a higher degree of
skewing toward the wild-type X chromosome are much
less likely to exhibit the scored phenotypes than those
with more balanced XCI. A high degree of skewing will
even prevent the appearance of any of the four phe-
notypes and will cause the females carrying most of the
cells that express the wild-type Mecp2 allele to be in-
distinguishable from their wild-type litter mates.
Our finding that the pattern of XCI correlates with
the phenotypic outcome of a truncation in Mecp2 is
relevant to the human disease in several ways. First, on
the basis of the data presented here, we propose that
there might be more females carrying mutations in
MECP2 than are currently accounted for. These females
are probably misdiagnosed or not even identified unless
they have an affected child. Second, although the limited
amount of information precludes a definitive ascertain-
ment, the data suggest that the forepaw/hand stereop-
typies might be associated with dysfunction of catecho-
laminergic neurons (mouse 6 in table 1) and that the Trs
might have a cortical origin (mouse 4 in table 1). Thus,
the observation that nonrandom XCI patterns mitigate
the phenotypic manifestations and that these patterns
might diverge in different regions of the brain could be
exploited to identify which neurons might mediate a
particular phenotype in this mouse model.
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